Ethylene Glycol

Ethylene Glycol

SCHEMBL3899600

NCC1(c2ccccc2)CCC(=O)CC1.OCCO

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.61
MAOB P27338 1/20 0.61
TAAR1 Q96RJ0 1/20 0.61
DPP4 P27487 4/20 0.58
MEN1 O00255 1/20 0.50
CYP2C9 P11712 1/20 0.50
KMT2A Q03164 1/20 0.50
SLC6A3 Q01959 3/20 0.46
SLC6A4 P31645 2/20 0.46
SLC6A2 P23975 1/20 0.46
KCNA3 P22001 5/20 0.45
SMN1; SMN2 Q16637 2/20 0.39
HTT P42858 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31147460 0.83 MEN1 (0.53) MAOAMAOBTAAR1DPP4MEN1
SCHEMBL3965188 0.82 MEN1 (0.57) MAOAMAOBTAAR1DPP4MEN1
SCHEMBL31147331 0.80 MEN1 (0.50) MAOAMAOBTAAR1DPP4MEN1
SCHEMBL1492704 0.78 MAOB (1.00) MAOAMAOBTAAR1DPP4SLC6A3
SCHEMBL31147495 0.76 KMT2A (0.53) MAOAMAOBTAAR1MEN1CYP2C9
Hydrochloric Acid SCHEMBL6813615 0.76 MAOB (0.95) MAOAMAOBTAAR1DPP4SLC6A3
SCHEMBL13938140 0.75 MEN1 (0.57) MAOAMAOBTAAR1DPP4MEN1
SCHEMBL294970 0.74 DPP4 (0.91) MAOAMAOBTAAR1DPP4SLC6A3
SCHEMBL294582 0.74 DPP4 (1.00) MAOAMAOBTAAR1DPP4SLC6A3
Carbamic Acid SCHEMBL10009301 0.74 DPP4 (0.75) MAOAMAOBTAAR1DPP4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1143965-B1 CARBOCYCLIC POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2009-02-25 EP disclosed
EP-1126836-B1 BENZAMIDE POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2007-02-14 EP disclosed
US-6632836-B1 To treat autoimmune disorders, cardiac arrhythmias and the like MERCK & CO., INC. 2003-10-14 US disclosed
EP-1143965-A4 CARBOCYCLIC POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2002-10-09 EP disclosed
EP-1126836-A4 BENZAMIDE POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2002-09-04 EP disclosed
EP-1143965-A1 CARBOCYCLIC POTASSIUM CHANNEL INHIBITORS Merck & Co., Inc. (US) 2001-10-17 EP disclosed
EP-1126836-A1 BENZAMIDE POTASSIUM CHANNEL INHIBITORS Merck & Co., Inc. (US) 2001-08-29 EP disclosed
US-6194458-B1 1-(2-METHOXYPHENYL)-1-OXO-2-AZA-(S)-4-I-BUTYL-4-PHENYLBUTANE, FOR EXAMPLE; TREATING VARIOUS CONDITIONS INCLUDING TRANSPLANTATION REJECTION OF ORGANS OR TISSUES IN A PATIENT; IMMUNOSUPPRESSANT COMPOSITIONS MERCK & CO., INC. 2001-02-27 US disclosed
WO-2000025770-A1 CARBOCYCLIC POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2000-05-11 WO disclosed
WO-2000025774-A1 BENZAMIDE POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2000-05-11 WO disclosed